In summary, our long-term observational data provide circumstantial evidence that HLA-B*57, a host genetic factor conferring immune-mediated protection in untreated HCV and HIV infection, may exert opposite effects on survival, when the disease course is altered by antiretroviral therapy. Here, HLA-B is linked to HIV infectious disease.